How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape (Q34194261)

31 July 2017

1 reference

title

How familial cancer genes and environmentally induced oncogenes have changed the endocrine landscape (English)

1 reference

31 July 2017

Asa SL

1

1 reference

31 July 2017

publication date

1 March 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

14

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

246-253

1 reference

C-Cell Hyperplasia Preceding Medullary Thyroid Carcinoma

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Activation of a novel human transforming gene, ret, by DNA rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Mutations of the RET proto-oncogene in Hirschsprung's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Functional receptor for GDNF encoded by the c-ret proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

GDNF signalling through the Ret receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Characterization of a multicomponent receptor for GDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Mitogenic signaling by Ret/ptc2 requires association with enigma via a LIM domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Hürthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Oxyphilic papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

“Warthin-like Tumor” of the Thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

Hyalinizing Trabecular Tumor of the Thyroid: A Variant of Papillary Carcinoma Proved By Molecular Genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

Symptomatic C-cell Hyperplasia Associated With Chronic Lymphocytic Thyroiditis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

A Rapid Screening Method for the Detection of Mutations in the RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2A and Familial Medullary Thyroid Carcinoma Families

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

The WHO histological classification of thyroid tumors: a commentary on the second edition

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

Papillary carcinoma of the thyroid, oxyphil cell type, "clear cell" variant: a light- and electron-microscopic study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

Hurthle cell variant of papillary carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

RET/PTC activation in hyalinizing trabecular tumors of the thyroid

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880293

7 January 2021

10.1038/MODPATHOL.3880293

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1043680744

0 references

1 reference